Multipurpose prevention technologies for the prevention of unintended pregnancy, HIV, and other sexually transmitted infections: regulatory pathways and challenges.
PMID : 40433453 ·
L, o, g, a, n, , D, o, n, a, l, d, s, o, n, ;, , R, o, b, i, n, , S, c, h, a, e, f, e, r, ;, , S, a, r, a, h, , A, l, h, a, k, i, m, i, ;, , R, u, t, h, , A, k, u, l, u, ;, , T, h, e, s, l, a, , P, a, l, a, n, e, e, -, P, h, i, l, l, i, p, s, ;, , B, e, t, h, a, n, y, , Y, o, u, n, g, , H, o, l, t, ;, , V, e, r, o, n, i, c, a, , M, i, l, l, e, r
Publicité
Résumé
Multipurpose prevention technologies (MPTs) are multi-indication products commonly focusing on the prevention of unintended pregnancy, HIV, and/or other sexually transmitted infections (STIs). MPTs have the potential to simplify product use and service delivery with reduced clinic visits, thus supporting improved product uptake, effective use, and cost-effectiveness. MPTs are complex products that typically include multiple active pharmaceutical ingredients (APIs), with two or more indications,
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.